Why is Morepen Labs. falling/rising?

As of 08-Jul, Morepen Laboratories Ltd is experiencing a decline in its stock price, currently at 63.45, which reflects a decrease of 0.25 or 0.39%. The stock has been underperforming recently, having fallen consecutively for the last two days with a total decline of 2.74%. Despite outperforming its sector by 0.54% today, the stock's delivery volume has decreased by 17.1% compared to the 5-day average, indicating a drop in investor participation. Over the past month, the stock has shown a negative return of 1.03%, while it has generated a positive return of 6.26% over the last year, suggesting some resilience in the long term despite recent struggles.
In the broader market context, Morepen Laboratories Ltd's short-term performance has been relatively weak compared to the benchmark, with a 1-week return of 2.22% against a negligible increase of 0.02% in the Sensex. While the stock has demonstrated strong long-term growth, with an annual operating profit growth rate of 35.63% and a favorable return on equity of 10.2%, its year-to-date performance shows a significant decline of 18.97% compared to the Sensex's 7.13% increase. This contrast highlights the stock's volatility and the challenges it faces in the current market environment, despite its attractive valuation and historical outperformance over longer periods.